Browsing by Author Dranitsaris, G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 6 of 6
TitleAuthor(s)Issue date
Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasiaHatzimichael, E.; Benetatos, L.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Georgiou, I.; Syrrou, M.; Stebbing, J.; Coley, H. M.; Crook, T.; Bourantas, K. L.24-Nov-2015
Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implicationsHatzimichael, E.; Dasoula, A.; Kounnis, V.; Benetatos, L.; Nigro, C. L.; Lattanzio, L.; Papoudou-Bai, A.; Dranitsaris, G.; Briasoulis, E.; Crook, T.24-Nov-2015
CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromesBenetatos, L.; Hatzimichael, E.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Syrrou, M.; Georgiou, I.; Bourantas, K. L.24-Nov-2015
Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactionsBenetatos, L.; Dasoula, A.; Hatzimichael, E.; Syed, N.; Voukelatou, M.; Dranitsaris, G.; Bourantas, K. L.; Crook, T.24-Nov-2015
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasiaHatzimichael, E.; Dasoula, A.; Shah, R.; Syed, N.; Papoudou-Bai, A.; Coley, H. M.; Dranitsaris, G.; Bourantas, K. L.; Stebbing, J.; Crook, T.24-Nov-2015
Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone diseaseHatzimichael, E.; Dranitsaris, G.; Dasoula, A.; Benetatos, L.; Stebbing, J.; Crook, T.; Bourantas, K. L.24-Nov-2015